Clinically significant therapeutic interactions for the practicing dermatologist.
Lebwohl
M
M
Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA.
Gelfand
J M
JM
Tan
M H
MH
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000494:pharmacology; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000494:pharmacology; D003880:Dermatology / Q000379:methods; D004347:Drug Interactions; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D008727:Methotrexate / Q000494:pharmacology; D011701:PUVA Therapy; D017319:Photosensitizing Agents / Q000008:administration & dosage / Q000494:pharmacology; D010818:Practice Patterns, Physicians'; D011565:Psoriasis / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D003879:Dermatologic Agents; D017319:Photosensitizing Agents; D004917:Erythromycin; D016572:Cyclosporine; D008727:Methotrexate